No Detail Found!

Metabolic syndrome and chronic diseases in Iran; A case - control meta-analysis

Author(s)
Khadijeh Kalan Farmanfarma Department of Epidemiology & Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences,Zahedan,Iran
Mahmoud Ali Kaykhaei Department of Epidemiology & Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences,Zahedan,Iran
Mehdi Mohammadi Department of Epidemiology & Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences,Zahedan,Iran
Hosein Ali Adineh Department of Epidemiology & biostatistics, School of health, Iranshahr University of Medical Sciences, Iranshahr, Iran.
Alireza Ansari-Moghaddam Department of Epidemiology & Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Abstract
To quantify the frequency of metabolic syndrome amongst individuals suffering from some chronic diseases and to compare them with the data obtained from healthy population. Methods: Manuscripts published on the prevalence of metabolic syndrome between 2000 and 2016 were identified through the following databases; Magiran, SID, and Iran Medex as well as PUBMED, EMBASE, MEDLINE, Web of Science, Scopus, and Google scholar using related MESH terms. Studies included if they had published quantitative estimates and measure of variability and/or confidence limits in the individual with the following diseases: diabetes, cardiovascular disease, cancer, periodontal, arthritis, polycystic ovary syndrome, Non-alcoholic fatty liver, psychiatric disorder, kidney and chronic disease. Data were analyzed with Stata, version 11. Results: A total of 62 articles selected for the final stage of this meta-analysis. The pooled prevalence of metabolic syndrome among diabetes, those with cardiovascular diseases, cases with renal failure, patients with NAFLD, periodontal subjects and individuals by arthritis were significantly higher than healthy population (P < 0.05). The risk of aforementioned diseases was found to be two to six times higher in those with metabolic syndrome than the normal population. Comparably, there was an inverse association between metabolic syndrome and mental disorders. Conclusions: Our findings suggest the early recognition, control and prevention of the metabolic syndrome and its individual components in the general population.
Publication Details
Page(s) 113-123
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Metabolic syndrome, Chronic disease, Prevalence, Prevalence
References
Xiao J,Wu CL,Gao YX,Wang SL,Wang L,Lu QY .2016 .Prevalence of metabolic syndrome and its risk factors among rural adults in Nantong, China. Sci Rep, 6 : 38089.
Sarebanhassanabadi M,Mirhosseini SJ,Mirzaei M,Namayandeh SM,Soltani MH,Pedarzadeh A .2017 .The incidence of metabolic syndrome and the most powerful components as predictors of metabolic syndrome in Central Iran: a 10-year follow-up in a cohort study. Iranian Red Crescent Med, 19(7) : e14934.
Neto L,Garcia JC,Xavier MDA,Borges JWP,Araújo MFMD,Damasceno MM .2017 .Prevalence of metabolic syndrome in individuals with type 2 diabetes mellitus. Rev Bras Enferm, 70(2) : 265-70.
Kim CJ,Park J,Kang SW J .2015 .Prevalence of metabolic syndrome and cardiovascular risk level in a vulnerable population. Int J Nurs Pract, 21(2) : 175-83.
Shahrokh S,Heydarian P,Ahmadi F .2012 .Association of inflammatory biomarkers with metabolic syndrome in hemodialysis patients. Ren Fail, 34(9) : 1109-13.
Gomes AR,de Sousa AW .2016 .Nonalcoholic Fatty Liver Disease in Metabolic Syndrome, Epidemiology and Pathogenesis. SmGroup, : 1-15.
Dragsbaek K,Neergaard JS,Laursen JM,Hansen HB,Christiansen C,Beck-Nielsen H .2016 .Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: challenging the current definition. Medicine, 95(36) : e4806.
Yang KC,Hung HF,Lu CW,Chang HH,Lee LT,KC. LT .2016 .Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance. Sci Rep, 6 : 27034.
Daudt LD,Musskopf ML,Mendez M,Remonti LLR,Leitão CB,Gross JL .2018 .Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. Braz Oral Res, 32 : e35.
Alizadeh S,Ahmadi M,Ghorbani Nejad B,Djazayeri A,ShabBidar S A .2018 .Metabolic syndrome and its components are associated with increased chronic kidney disease risk: Evidence from a metaanalysis on 11 109 003 participants from 66 studies. Int J Clin Pract, 72 : e13201.
Alfa-Wali M,Boniface S,Sharma A,Tekkis P,Hackshaw A,Antoniou A .2015 .Metabolic syndrome (MetS) and risk of colorectal cancer (CRC): a systematic review and meta-analysis. World J Surg Med, 4(7) : 41-52.
Kamkar MZ,Sanagoo A,Zargarani F,Jouybari L,Marjani A .2016 .Metabolic syndrome in patients with severe mental illness in Gorgan. J Nat Sc Biol Med, 7(1) : 62-7.
Lee SH,Choi H,Cho BL,An AR,Seo YG,Jin HS .2016 .Relationship between metabolic syndrome and rheumatoid arthritis. Korean J Fam Med, 37(1) : 44-50.
Kaykhaei MA,Adineh HA,Mohammadi M,Dabiri S,Ansari-Moghaddam A .2019 .Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies. Diabetes Metab Syndr, 13(1) : 792-99.
Mohagheghi A,Panahi A,Hedayat DK .2011 .The effects of metabolic syndrome on left main coronary artery stenosis in coronary angiograms of patients: a two year study. TUMS, 69(9) : 571-75.
Hadaegh F,Zabetian A,Tohidi M .2008 .Relationship between metabolic syndrome and coronary heart disease in Iranian population the Tehran lipid and glucose study. Tehran Univ Med J, 66(8) : 590-98.
Assali A,Ghayour-Mobarhan M,Sahebkar A,Hassani M,Kasaian J,Tatari F .2011 .Association of angiotensin II type 1 receptor gene A1166C polymorphism with the presence of diabetes mellitus and metabolic syndrome in patients with documented coronary artery disease. Eur J Intern Med, 22(3) : 254-61.
Ghanei Gheshlagh R,Nourozi Tabrizi K,Shabani F,Zahednezhad H .2016 .Association between metabolic syndrome and sleep apnea in elderly patients with cardiovascular diseases. Med Sci J Islamic Azad Univ Tehran Med Branch, 26(1) : 46-51.
Ardeshiri M,Faritus Z,Ojaghi-Haghighi Z,Bakhshandeh H,Kargar F,Aghili R .2014 .Impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery. Res Cardiovasc Med, 3(3) : e20270.
Anvari MS,Boroumand MA,Pourgholi L,Sheikhfathollahi M,Rouhzendeh M,Rabbani S .2009 .Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography. Arch Med Res, 40(5) : 399-405.
Sadeghian S,Darvish S,Salimi S,Esfehani FA,Fallah N,Mahmoodian M .2007 .Metabolic syndrome: stronger association with coronary artery disease in young men in comparison with higher prevalence in young women. Coron Artery Dis, 18(3) : 163-8.
Mahdavi Anari L,Ghanbari-Firoozabadi M,Ansari Z,Emami M,Vafaii Nasab M,Nemaiande M .2015 .Effect of Cardiac Rehabilitation Program on Heart Rate Recovery in Coronary Heart Disease. J Teh Univ Heart Ctr, 10(4) : 176-81.
Harandi SA,Sarrafzadegan N,Sadeghi M,Talaei M,Dianatkhah M,Oveisgharan S .2016 .Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?. ResCardiovasc Med, 5(1) : e30619.
Kabir A,Sarrafzadegan N,Amini A,Aryan RS,Kerahroodi FH,Rabiei K .2012 .Impact of cardiac rehabilitation on metabolic syndrome in Iranian patients with coronary heart disease: the role of obesity. Rehabil Nurs, 37(2) : 66-73.
Parizadeh SA,Jamialahmadi K,Rooki H,Zaim-Kohan H,Mirhafez SR,Hosseini N .2015 .Association of neuropeptide Y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease. Ann Hum Biol, 42(2) : 179-83.
Dehghani MR,Rezaei Y,Fakour S,Arjmand N. .2016 .White blood cell count to mean platelet volume ratio is a prognostic factor in patients with non-ST elevation acute coronary syndrome with or without metabolic syndrome. Korean Circ J, 46(2) : 229-38.
Sarrafzadegann N,Ashrafi F,Noorbakhsh M,Haghighi M,Sadeghi M,Mazaheri F .2009 .Association of breast artery calcification with coronary artery disease and carotid intima-media thickness in premenopausal women. East Mediterr Health J, 15(6) : 1474-82.
Sadr Bafghi S M M,Namayande S M A,Soltani MH,Motefaker M .2005 .Examination of premature myocardial infarction in Yazd. TUMJ, 7 : 579-89.
Saeidi M. Metabolic .2009 .Syndrome and Hypertension in Diabetic Patients. IJEM, 11(1) : 11-16.
Nakhjavani N,Imani M,Larry M,Aghajani-Nargesi A,Morteza A,Esteghamati A .2014 .Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status. J Diabetes Metab Disord, 13(1) : 102.
Marjani A,Shirafkan A .2011 .The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions. Diabetes Metab Syndr, 5(4) : 207-10.
Rashidi H,Fardad F,Ghaderian B,Shahbazian HB,Latifi M,Karandish M .2012 .Prevalence ofMetabolic Syndrome and its Predicting Factors in Type 2 Diabetic Patients in Ahvaz. Jundishapur Sci Med J, 11(1) : 163-75.
Foroozanfar Z,Najafipour H,Khanjani N,Bahrampour A,Ebrahimi H . .2015 .The Prevalence of Metabolic Syndrome According to Different Criteria and its Associated Factors in Type 2 Diabetic Patients in Kerman, Iran. Iran J Med Sci, 40(6) : 522-25.
Ziaee A,Hashemipoor S,Karimzadeh T,Jalalpoor A,Javadi A .2012 .Relation of Vitamin D3 Level with metabolic Syndrome Indices among Patients with Diabetes and Non-Diabetic Individuals. J Ardabil Univ Med Sci, 12(2) : 149-56.
Derakhshan R,Khoshnood A,Balaee P .2010 .Evaluation of Abdominal Obesity Prevalence in Diabetic Patients and Relation with Other Factors of Metabolic Syndrome. IJEM, 12(3) : 208-12.
Hosseinpanah F,Rambod M,Sadeghi L,Foroutan M,Naseri M .2006 .Assessing predicting factors in non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes. , 30(1) : 9-15.
Nargesi AA,Esteghamati S,Heidari B,Hafezi-Nejad N,Sheikhbahaei S,Pajouhi A .2016 .Nonlinear relation between pulse pressure and coronary heart disease in patients with type 2 diabetes or hypertension. J Hypertens, 34(5) : 974-80.
Sharifi F,Jaberi Y,Mirzamohammadi F,Mirzamohammadi H,Mousavinasab N. .2013 .Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose. Indian J Endocrinol Metab, 17(5) : 899-905.
Gholamzadeh Baeis M,Mohebi S,Miladinia M,Parham M. .2016 .Study of Metabolic Syndrome Based on the NCEP/ATP III Criteria in People at Risk for Diabetes. Qom Univ Med Sci J, 10(6) : 42-50.
Veissi M,Anari R,Amani R,Shahbazian H,Latifi SM .2016 .Mediterranean diet and metabolic syndrome prevalence in type 2 diabetes patients in Ahvaz, southwest of Iran. Diabetes Metab Syndr, 10(2 Suppl 1) : S26-29.
Vafaeimanesh J,Bagherzadeh M,Mirzaei A,Parham M,Norouzinia M,Vafaee R .2016 .Effect of Helicobacter pylori on metabolic syndrome parameters in diabetic patients. Gastroenterol Hepatol Bed Bench, 9(Suppl1) : S36-S41.
Nakhjavani M,Esteghamati A,Tarafdari AM,Nikzamir A,Ashraf H,Abbasi M. .2011 .Association of plasma leptin levels and insulin resistance in diabetic women: a cross-sectional analysis in an Iranian population with different results in men and women. Gynecol Endocrinol, 27(1) : 14-9.
Janghorbani M,Amini M. .2016 .Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study. , 68(1) : 19-25.
Sobhani N,Entezari MH,Feizi A,Asgari GH,Reiesi J .2016 .Association of Dietary Fatty Acids with Metabolic Syndrome Indices in Patients with Type 2 Diabetes. J Isfahan Med Sch, 34(383) : 563-71.
Bonakdaran SH,Gharebaghi M,Vahedian M. .2009 .Prevalance of Anemia in Type 2 Diabetic Patients and the Role of Nephropathy. Iranian Journal of Endocrinology & Metabolism, 11(2) : 127-34.
Jahed A,Hosseinpanah F .2007 .Prevalence and predictive factors of lada “latent autoimmune diabetes in adults” in newly diagnosed diabetics of tehran lipid and glucose study. Ijdld, 7(1) : 43-54.
Pourteymour Fard Tabrizi F,Alipoor B,Sadaghiani MM,Ostadrahimi A,Malek Mahdavi A .2013 .Metabolic syndrome and its characteristics among reproductive-aged women with polycystic ovary syndrome: A cross-sectional study in northwest Iran. Int J Fertil Steril, 6(4) : 244-49.
Moini A,Javanmard F,Eslami B,Aletaha N. .2012 .Prevalence of metabolic syndrome in polycystic ovarian syndrome women in a hospital of Tehran. Iran J Reprod Med, 10(2) : 127-30.
Shahbazian HB,Shahbazian N,Haghighi M,Khodadadi M. .2012 .Prevalence of Metabolic Syndrome in Patients with Poly Cystic Ovarian Syndrome in Ahvaz. Sci Med J, 10(6) : 595-604.
Mehrabian F,Khani B,Kelishadi R,Kermani N. .2011 .The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females. J Res Med Sci, 16(6) : 763-69.
Madani T,Hosseini R,Ramezanali F,Khalili G,Jahangiri N,Ahmadi J .2016 .Metabolic syndrome in infertile women with polycystic ovarian syndrome. Arch Endocrinol Metab, 60(3) : 199-204.
Zahiri Z,Sharami SH,Milani F,Mohammadi F,Kazemnejad E,Ebrahimi H .2016 .Metabolic syndrome in patients with polycystic ovary syndrome in Iran. Int J Fertil Steril, 9(4) : 490-96.
Layegh P,Mousavi Z,Tehrani DF,Parizadeh SM,Khajedaluee M. .2016 .Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and nonobese PCOS patients. Int J Reprod Biomed (Yazd), 14(4) : 263-70.
Ebrahimi-Mamaghani M,Saghafi-Asl M,Pirouzpanah S,Aliasgharzadeh A,Aliashrafi S,Rezayi N .2015 .Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome. J Health Popul Nutr, 33(1) : 157-67.
Moradi S,Darvishi N. .2009 .Evaluation of the Prevalence of Metabolic Syndrome in Women with Polycystic Ovary Syndrome Referred to the Institute of Endocrine and Metabolism. RJMS, 16(63) : 132-37.
Forootan M,Tabatabaeefar M,Yahyaei M,Maghsoodi N. .2012 .Metabolic syndrome and colorectal cancer: a cross-sectional survey. Asian Pacific J Cancer Prev, 13(10) : 4999-5002.
Saadatian V,Ghareh S,Shakeri MT,Emadzadeh M,Taraz Jamshidi SH,Emadzadeh A .2012 .The Frequency of Metabolic Syndrome among Female Patients Admitted in Psychiatry Ward. Medical Journal of Mashhad University of Medical Sciences, 54(4) : 230-37.
Rezaei O,Khodaie-Ardakani MR,Mandegar MH,Dogmehchi E,Goodarzynejad H .2009 .Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia. Int J Psychiatry Med, 39(4) : 451-62.
Khalili F .2015 .Metabolic syndrome in schizophrenic patients: prevalence and findings in Bandar Abbas. Intl Res J.Appl BasicSci, 9(11) : 1890-94.
Shakeri J,Karimi K,Farnia V,Golshani S,Alikhani M. .2016 .Prevalence of metabolic syndrome in patients with schizophrenia referred to farabi hospital, Kermanshah, Iran. Oman Med, 31(4) : 270-75.
Moayedi F,Abdolrasouli LH,Fardan Y,Hosseini S,Sadeghi P .2015 .Prevalence of metabolic syndrome among bipolar patients. RJ PBCS, 6(2) : 910-14.
Goughari AS,Mazhari S,Pourrahimi AM,Sadeghi MM,Nakhaee N. .2015 .Associations between components of metabolic syndrome and cognition in patients with schizophreni. J Psychiatr Pract, 21(3) : 190-97.
Ghoreishi A,Shajari Z,Sharifi F,Ghoreishi AB .2016 .Metabolic Syndrome, 10year-Coronary Heart Disease and 8year-Diabetes Mellitus Prediction in the Patients with Schizophrenia. Adv Biores, 7(4) : 155-62.
Ghanei Geshlagh R,Hemmati Maslakpak M,Ghoci S M .2011 .Sleep apnea and metabolic syndrome in hemodialysis patients. Urmia Medical Journal, 22(4) : 339-45.
Marjani A,Moujerloo M,Hezarkhani S M .2013 .Age related metabolic syndrome among hemodialysis patients in Gorgan, Iran. , 7 : 15-8.
Mortazavi M,Seirafian S,Naini AE,Zamani N,Moien N. .2012 .The Prevalence of Metabolic Syndrome in Patients on Hemodialysis and Peritoneal Dialysis: A Comparative Study. JIMS, 29 : 171.
Razeghi E,Heydarian P,Heydari M. .2011 .The frequency of prediabetes and contributing factors in patients with chronic kidney disease. Rev Diabet Stud, 8(2) : 276-81.
Maleki A,Montazeri M,Rashidi N,Montazeri M .2015 .Metabolic syndrome and its components associated with chronic kidney disease. Journal of research in medical sciences: the official. J Res Med Sci, 20(5) : 465-69.
Edalat-Nejad M,Zameni F,Qlich-Khani M .2015 .Geriatric nutritional risk index: a mortality predictor in hemodialysis patients. Saudi J Kidney Dis Transpl, 26(2) : 302-8.
Fattahi MR,Niknam R,Safarpour A,Sepehrimanesh M,Lotfi M. .2016 .The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study. Middle East J Dig Dis, 8(2) : 131-37.
Safavi F,Yousefzadeh GH,Shokoohi M,Safavi S,Najafipour H,Shadkam Farokhi M. H .2015 .Prevalence of metabolic syndrome in patients with periodontal disease. JKMU, 22(3) : 229-39.
Hossein Tehrani M,Karimi M,Kalhor L,Mazloumzade S. .2015 .Prevalence of Metabolic Syndrome and its Components in Patients with Osteoarthritis. J Adv Med Biomed Res, 23(96) : 68-77.
Goshayeshi L,Saber H,Sahebari M,Rezaieyazdi Z,Rafatpanah H,Esmaily H .2012 .Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis. Clin Rheumatol, 31(8) : 1197-203.
Shirani F,Khaleghi S,Nikfam M,Pourmojarab A .2016 .The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospitalbased cross-sectional study on Iranian population. TUMJ, 74(8) : 569-77.
Ford ES,Schulze MB,Pischon T,Bergmann MM,Joost HG,Boeing H .2008 .Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and NutritionPotsdam Study. Cardiovasc diabetol, 7(1) : 35.
Cheung BM,Wat NM,Man YB,Tam S,Thomas GN,Leung GM .2007 .Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes care, 30(6) : 1430-36.
Lorenzo C,Okoloise M,Williams K,Stern MP,Haffner SM .2003 .The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes care, 26(11) : 3153-59.
Mottillo S,Filion KB,Genest J,Joseph L,Pilote L,Poirier P .2010 .The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol, 56(14) : 1113-32.
Salman Roughani H,Mohammadi S M L,Salman Roughani R .2008 .ZaremehrjerdiA. Investigating the Indices of Insulin Resistance and Metabolic Syndrome in Patients with Asymptomatic Fatty Liver. Govaresh, 13(2) : 75-79.
Ghamar-Chehreh ME,Amini M,Khedmat H,Moayed Alavian S,Daraei F,Mohtashami R .2012 .Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver diseaseAsian. Pac J Trop Biomed, 2(9) : 702-6.
Noori N,Hosseinpanah F,Nasiri AA,Azizi F .2009 .Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr, 19(3) : 228-37.
Cho JA,Lee SJ,Reid EA,Jee SH .2013 .Metabolic syndrome component combinations and chronic kidney disease: the severance cohort study. Maturitas, 75(1) : 74-80.
Raikou V,Gavriil S. .2018 .Metabolic syndrome and chronic renal disease. Diseases, 6(1) : 12.
Naik M,Bhat T,Jalalie U,Ganayie M T,Waseem M,Bhat A .2017 .Prevalence and predictors of metabolic syndrome in rheumatoid arthritis. Int J Res Med Sci, 5(8) : 3322-28.
Lee SG,Kim JM,Lee SH,Kim KH,Kim JH,Yi JW .2013 .Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects?. Korean J Intern Med, 28(2) : 206-15.
Jinjuvadia R,Lohia P,Jinjuvadia C,Montoya S,Liangpunsakul S. .2013 .The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol, 47(1) : 33-44.
Lim HS,Shin EJ,Yeom JW,Park YH,Kim SK .2017 .Association between nutrient intake and metabolic syndrome in patients with colorectal cancer. Clin Nutr Res, 6(1) : 38-46.
Nibali L,Tatarakis N,Needleman I,Tu YK,D'Aiuto F,Rizzo M .2013 .Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. J Clin Endocrinol Metab, 98(3) : 913-20.
Kaye EK,Chen N,Cabral HJ,Vokonas P,Garcia RI .2016 .Metabolic syndrome and periodontal disease progression in men. J Dent Res, 95(7) : 822-28.
Hallajzadeh J,Khoramdad M,Karamzad N,Almasi-Hashiani A,Janati A,Ayubi E .2018 .Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis. J Cardiovasc Thorac Res, 10(2) : 56-69.
Vancampfort D,Vansteelandt K,De Herdt A,Sienaert P .2013 .Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry, 170(3) : 265-74.
0

Citations

0

Downloads

12

Views